HIDRADENITIS SUPPURATIVA (HS)

This study is testing an oral medication called povorcitinib in teenagers with moderate to severe hidradenitis suppurativa (HS), a painful skin condition. Over 54 weeks, researchers will measure how safe the drug is, how the body processes it, and whether it reduces HS symptoms l…

This study is testing whether an experimental drug called CIT-013 can reduce symptoms of hidradenitis suppurativa, a chronic inflammatory skin disease that causes painful lumps under the skin. 96 adults with moderate-to-severe HS who haven't responded well to antibiotics will rec…

This study allows people with hidradenitis suppurativa (HS) who benefited from the drug povorcitinib in earlier trials to continue taking it. The main goal is to monitor long-term safety and side effects in about 600 participants. It's for people who did well on the medication an…

This study is testing an investigational drug called tibulizumab for adults with moderate-to-severe hidradenitis suppurativa (HS), a chronic inflammatory skin condition. For the first 16 weeks, participants will be randomly assigned to receive either the drug or a placebo. Then, …

This study is testing whether an investigational drug called BFB759 can reduce painful skin lesions and improve quality of life for people with moderate to severe hidradenitis suppurativa (HS). About 210 adults whose HS isn't well controlled by antibiotics will receive either BFB…

This study is testing if an experimental drug called NAV-240 works better than a placebo to reduce painful skin bumps and tunnels in adults with moderate-to-severe hidradenitis suppurativa (HS). About 150 participants will receive either one of two doses of NAV-240 or a placebo t…

This study is testing whether a foam containing the drug roflumilast can help reduce painful lumps and abscesses in people with hidradenitis suppurativa (HS), a chronic inflammatory skin condition. About 20 adult participants with mild-to-moderate HS will apply the foam daily for…

This program provides access to the medication secukinumab for people with severe hidradenitis suppurativa, a painful skin condition. It's designed for patients who have tried all other available treatments without success and cannot join regular clinical trials. The program allo…

This study is testing if a special 1726-nm laser can safely reduce the painful lumps and abscesses caused by hidradenitis suppurativa (HS), a chronic skin condition. Adults with mild-to-moderate HS will have one side of their body treated with the real laser and the other side wi…

This study compares two wound dressings used after surgery for hidradenitis suppurativa, a painful skin condition. Researchers want to see if a newer dressing with silver and a pain reliever helps patients heal faster, with less pain and fewer infections, compared to the standard…

This study surveys adults in Saudi Arabia with moderate to severe hidradenitis suppurativa (HS), a painful skin condition, who are starting a new treatment called secukinumab. Researchers will ask patients about their treatment satisfaction, pain levels, and quality of life over …